Pirenzepine
![[2-(Diethylamino)Ethyl] Amino-5,11-Dihydro[1]](http://data.docslib.org/img/264x/266edf4eedd8a17642568c6b903a9db5.webp)
Top View
- Drug/Substance Trade Name(S)
- United States Patent (19) 11) Patent Number: 5,461,052 Stone Et Al
- Symptomatic Pharmacotherapy in ALS: Data Analysis from a Platform-Based Medication Management Programme
- Council of Europe Committee of Ministers (Partial
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- A Dissertation Entitled Development of a Pharmacological Screen for M5
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Antimuscarinic Effects of Amitriptyline Hci and Opipramole Hci in Rat Ileum and Rat Duodenum
- Medicine Directory
- Investigation of M1/M4 Muscarinic Receptors in the Anterior Cingulate Cortex in Schizophrenia, Bipolar Disorder, and Major Depression Disorder
- Handy Fact Sheet Sialorrhoea (Hypersalivation) from Clozapine
- PHARMACOLOGICAL DETERMINATION of the Pa for PIRENZEPINE USING a MAMMALIAN in VITRO BRAIN SLICE PREPARATION
- Protocol Revision Date 12-09-2014 Page 1 of 52 Title of the Study
- Assessing the Safety of Drugs for the Long-Term Treatment of Peptic Ulcers K G WORMSLEY from the Department of Therapeutics, University Ofdundee, Dundee, Scotland
- Comparison of Antiulcer Effects of Tricyclic Antidepressants with Cimetidine and Omeprazole in Rats
- Disturbed Ca Signaling and Apoptosis of Medium Spiny Neurons In
- Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
- Literature Search Strategy for Treatment of Stable